2018 US Cell Surface Testing Market: Supplier Shares and Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
Complete report $2,250. DataPack (test volumes, sales forecasts, supplier shares) $1,450.
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies.
During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 115 pages and 6 tables
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies.
During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Contains 115 pages and 6 tables
I. INTRODUCTION
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
Electrical ApertureImpedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
DrewScientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. FLOW CYTOMETERS
a. INTRODUCTION
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
III. U.S.: Forecasts by Test and Market Segment
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
TESTING MARKETS
1. FOUR MARKETING APPROACHES
2. PRODUCT COMPLEXITY FACTOR
3. CUSTOMER PREFERENCE FACTOR
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION FACTOR
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
BioRad
CellaVision
Horiba
Iris/Danaher
Nihon Kohden
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
VII. Appendix: Major Universities and Research Centers Developing Hematology/Flow Cytometry Technologies and Applications
II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
BD
Beckman Coulter/Danaher
T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
Electrical ApertureImpedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
DrewScientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. FLOW CYTOMETERS
a. INTRODUCTION
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
III. U.S.: Forecasts by Test and Market Segment
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
TESTING MARKETS
1. FOUR MARKETING APPROACHES
2. PRODUCT COMPLEXITY FACTOR
3. CUSTOMER PREFERENCE FACTOR
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION FACTOR
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
Becton Dickinson
BioRad
CellaVision
Horiba
Iris/Danaher
Nihon Kohden
OrthoClinical Diagnostics
Roche
Siemens
Sysmex
VII. Appendix: Major Universities and Research Centers Developing Hematology/Flow Cytometry Technologies and Applications
LIST OF TABLES
U.S., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated Cell Surface Marker Test Volume
U.S., Flow Cytometry Consumables Market By Major Supplier
U.S., Flow Cytometry Instrument Market By Major Supplier
U.S., Flow Cytometry Diagnostics Market By Major Supplier
U.S., Hospital Laboratories Estimated Cell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated Cell Surface Marker Test Volume
U.S., Flow Cytometry Consumables Market By Major Supplier
U.S., Flow Cytometry Instrument Market By Major Supplier
U.S., Flow Cytometry Diagnostics Market By Major Supplier
